Regulatory Rumblings
Navigating Web 3.0: Data Security and Privacy in the Age of GDPR
Posted: Feb 1, 2018 12:00pm ETThis May, companies on both sides of the pond will see what is arguably the largest overhaul of personal data privacy rules in the Internet Era, otherwise known as the General Data Protection Regulation (GDPR).
READ MORENew Commissioners on the way for the FTC
Posted: Jan 26, 2018 10:45am ETYesterday, the White House announced that it has sent the nominations of four new Commissioners for the Federal Trade Commission (FTC) to the Senate for approval.
READ MOREGDPR Tightens Key Consent and Profiling Rules for Advertisers
Posted: Jan 11, 2018 2:30pm ETTraps abound for marketers responsible for EU-related activities as the May 2018 EU General Data Protection Regulation (GDPR) compliance deadline approaches. Recent EU guidance about consent for personal data collection and use and guidance on using data for profiling purposes reinforce the belief that EU regulators will be prone to broadly apply GDPR to marketing activities.
READ MORENew Year, New Legislative Challenges ANA is Ready to Tackle
Posted: Jan 4, 2018 2:00pm ETAs we reflect upon the past year, ANA is very proud to have ended 2017 on a high note with an important victory for the advertising industry, the preservation of advertising deductions in the Tax Cuts and Jobs Act.
READ MOREProtecting the Tax Deductibility of DTC Advertising
Posted: Dec 12, 2017 3:30pm ETThe U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing today on the cost of prescription drugs, including discussion of a report from the National Academy of Sciences that included a recommendation that Congress “should disallow the tax deductibility of direct-to-consumer advertising of prescription drugs as a business expense.”
READ MORELimiting Available Health Info is Bad for America
Posted: Dec 5, 2017 2:30pm ETLast week, the National Academy of Sciences issued a new report, “Making Medicines Affordable: A National Imperative,” which, among other proposals, recommends that the tax deduction for prescription drug advertising be removed.
READ MOREIt’s not over till it’s over
Posted: Nov 17, 2017 11:30am ETYesterday, the House passed its version of the Tax Cuts and Jobs Act – the long-awaited tax reform package that was promised by President Trump. On the Senate side, a somewhat different version of the bill passed through the Finance Committee after several days of debate over amendments.
READ MOREPharma Ads Threatened in Senate
Posted: Nov 14, 2017 9:15am ETSenator Claire McCaskill (D-MO) suddenly and unexpectedly has filed an amendment to the Tax Cuts & Jobs Act released by Chairman Hatch. Her amendment would totally eliminate the advertising costs deduction for pharmaceutical companies.
READ MORENinth Circuit A Hotspot for Troubling Advertising Law
Posted: Oct 27, 2017 9:00am ETRecent action by the Ninth Circuit U.S. Court of Appeals has taken a troubling turn away from the trajectory of increasing First Amendment protections for commercial speech.
READ MOREPai to Remain as Strong Leader of the FCC
Posted: Oct 4, 2017 10:20am ETThe Senate reconfirmed Federal Communications Commission (FCC) Chairman Ajit Pai to a new five-year term earlier this week. Chairman Pai has been serving as head of the agency since January, when he was selected by President Trump as the Administration’s top regulator of the communications industry.
READ MORE